Medtronic reported a decline in third-quarter profit, even though revenue increased. The company cited higher costs and significant investments in its business as the primary reasons for the drop. This outcome suggests operational challenges or strategic spending are currently outweighing revenue gains for the medical device giant.

Investors may view this as a sign of pressure on margins, potentially impacting Medtronic's stock performance and future guidance. The results highlight the difficulty companies face in balancing growth investments with maintaining profitability.